BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31914820)

  • 1. Novel methods in glycomics: a 2019 update.
    Cao WQ; Liu MQ; Kong SY; Wu MX; Huang ZZ; Yang PY
    Expert Rev Proteomics; 2020 Jan; 17(1):11-25. PubMed ID: 31914820
    [No Abstract]   [Full Text] [Related]  

  • 2. Mass spectrometry and the emerging field of glycomics.
    Zaia J
    Chem Biol; 2008 Sep; 15(9):881-92. PubMed ID: 18804025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative versus absolute quantitation in disease glycomics.
    Moh ES; Thaysen-Andersen M; Packer NH
    Proteomics Clin Appl; 2015 Apr; 9(3-4):368-82. PubMed ID: 25684231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying cancer biomarkers by mass spectrometry-based glycomics.
    Mechref Y; Hu Y; Garcia A; Hussein A
    Electrophoresis; 2012 Jul; 33(12):1755-67. PubMed ID: 22740464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry and glycomics.
    Zaia J
    OMICS; 2010 Aug; 14(4):401-18. PubMed ID: 20443730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in mass spectrometry-based glycomics.
    Dong X; Huang Y; Cho BG; Zhong J; Gautam S; Peng W; Williamson SD; Banazadeh A; Torres-Ulloa KY; Mechref Y
    Electrophoresis; 2018 Dec; 39(24):3063-3081. PubMed ID: 30199110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative glycomics.
    Orlando R
    Methods Mol Biol; 2010; 600():31-49. PubMed ID: 19882119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in ion mobility-mass spectrometry for improved structural characterization of glycans and glycoconjugates.
    Chen Z; Glover MS; Li L
    Curr Opin Chem Biol; 2018 Feb; 42():1-8. PubMed ID: 29080446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 1.
    Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
    Expert Rev Proteomics; 2018 Feb; 15(2):165-182. PubMed ID: 29285957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass Spectrometry Approaches to Glycomic and Glycoproteomic Analyses.
    Ruhaak LR; Xu G; Li Q; Goonatilleke E; Lebrilla CB
    Chem Rev; 2018 Sep; 118(17):7886-7930. PubMed ID: 29553244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mass spectrometry-based glycotope-centric cellular glycomics is the more fruitful way forward to see the forest for the trees.
    Khoo KH
    Biochem Soc Trans; 2021 Feb; 49(1):55-69. PubMed ID: 33492355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GlycoNote with Iterative Decoy Searching and Open-Search Component Analysis for High-Throughput and Reliable Glycan Spectral Interpretation.
    Liu MQ; Treves G; Amicucci M; Guerrero A; Xu G; Gong TQ; Davis J; Park D; Galermo A; Wu L; Cao W; Lebrilla CB
    Anal Chem; 2023 May; 95(21):8223-8231. PubMed ID: 37194568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
    Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
    J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sweet systems: technologies for glycomic analysis and their integration into systems biology.
    Chen S; Qin R; Mahal LK
    Crit Rev Biochem Mol Biol; 2021 Jun; 56(3):301-320. PubMed ID: 33820453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of asparagine-linked glycan structure databases and their use.
    Gao HY
    J Am Soc Mass Spectrom; 2009 Sep; 20(9):1739-42. PubMed ID: 19556140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of analytical methods for profiling N- and O-linked glycans from cultured cell lines : HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study.
    Ito H; Kaji H; Togayachi A; Azadi P; Ishihara M; Geyer R; Galuska C; Geyer H; Kakehi K; Kinoshita M; Karlsson NG; Jin C; Kato K; Yagi H; Kondo S; Kawasaki N; Hashii N; Kolarich D; Stavenhagen K; Packer NH; Thaysen-Andersen M; Nakano M; Taniguchi N; Kurimoto A; Wada Y; Tajiri M; Yang P; Cao W; Li H; Rudd PM; Narimatsu H
    Glycoconj J; 2016 Jun; 33(3):405-415. PubMed ID: 26511985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycomics and disease markers.
    An HJ; Kronewitter SR; de Leoz ML; Lebrilla CB
    Curr Opin Chem Biol; 2009 Dec; 13(5-6):601-7. PubMed ID: 19775929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 2.
    Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
    Expert Rev Proteomics; 2018 Apr; 15(4):341-352. PubMed ID: 29521143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass Spectrometry-Based N-Glycomics of Colorectal Cancer.
    Sethi MK; Fanayan S
    Int J Mol Sci; 2015 Dec; 16(12):29278-304. PubMed ID: 26690136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry in the analysis of N-linked and O-linked glycans.
    North SJ; Hitchen PG; Haslam SM; Dell A
    Curr Opin Struct Biol; 2009 Oct; 19(5):498-506. PubMed ID: 19577919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.